Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 9/30/2024 | 9/27/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $256 | – | $264 | $202 |
| Dep. & Amort. | $99 | – | $87 | $96 |
| Deferred Tax | $5 | – | -$22 | -$18 |
| Stock-Based Comp. | $129 | – | $120 | $118 |
| Change in WC | -$17 | – | -$119 | -$47 |
| Other Non-Cash | $1 | – | -$4 | $17 |
| Operating Cash Flow | $472 | – | $327 | $367 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$36 | – | -$30 | -$30 |
| Net Acquisitions | -$1 | – | -$488 | $26 |
| Inv. Purchases | -$0 | – | -$160 | -$173 |
| Inv. Sales/Matur. | $16 | – | $392 | $232 |
| Other Inv. Act. | $11 | – | $0 | $0 |
| Investing Cash Flow | -$11 | – | -$286 | $54 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | – | $0 | $0 |
| Stock Issued | $44 | – | $40 | $48 |
| Stock Repurch. | -$162 | – | -$199 | -$180 |
| Dividends Paid | -$127 | – | -$115 | -$103 |
| Other Fin. Act. | -$2 | – | -$14 | -$1 |
| Financing Cash Flow | -$247 | – | -$288 | -$237 |
| Forex Effect | $1 | – | $7 | $5 |
| Net Chg. in Cash | $216 | – | -$240 | $190 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $578 | – | $818 | $628 |
| End Cash | $793 | – | $578 | $818 |
| Free Cash Flow | $430 | – | $297 | $337 |